Darwin Global Management, Ltd. Quant / Systematic

CIK: 0001839209 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value ($000): $751,168 (100.0% shares, 0.0% debt)

Holdings (12)

PCVX VAXCYTE INC 25.0%

Value ($000) $187,907 Shares 2,750,804 Est. Cost $65.60 Unrealized +5.6%

NUVL NUVALENT INC 14.4%

Value ($000) $107,902 Shares 1,436,964 Est. Cost $78.87 Unrealized +0.9%

KROS KEROS THERAPEUTICS INC 12.7%

Value ($000) $95,060 Shares 1,435,950 Est. Cost $38.66 Unrealized +53.4%

BHVN BIOHAVEN LTD 10.8%

Value ($000) $80,776 Shares 1,476,974 Est. Cost $49.52 Unrealized 0.0%

— ALPINE IMMUNE SCIENCES INC 10.5%

Value ($000) $78,567 Shares 1,982,016 Est. Cost $39.64 Unrealized —

BEAM BEAM THERAPEUTICS INC 9.3%

Value ($000) $70,032 Shares 2,119,598 Est. Cost $31.16 Unrealized 0.0%

APGE APOGEE THERAPEUTICS INC 7.4%

Value ($000) $55,300 Shares 832,198 Est. Cost $43.66 Unrealized 0.0%

XNCR XENCOR INC 3.3%

Value ($000) $24,557 Shares 1,109,650 Est. Cost $21.61 Unrealized 0.0%

SYRE SPYRE THERAPEUTICS INC 2.4%

Value ($000) $17,948 Shares 473,200 Est. Cost $28.97 Unrealized 0.0%

— ELEVATION ONCOLOGY INC 1.6%

Value ($000) $11,968 Shares 2,332,928 Est. Cost $5.13 Unrealized —

— TOURMALINE BIO INC 1.4%

Value ($000) $10,649 Shares 465,000 Est. Cost $22.90 Unrealized —

MRK MERCK & CO INC 1.4%

Value ($000) $10,503 Shares 79,600 Est. Cost $115.77 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PCVX	VAXCYTE INC	2,750,804	$187,907	25.0%	$65.60	+5.6%	COM	92243G108
NUVL	NUVALENT INC	1,436,964	$107,902	14.4%	$78.87	+0.9%	COM	670703107
KROS	KEROS THERAPEUTICS INC	1,435,950	$95,060	12.7%	$38.66	+53.4%	COM	492327101
BHVN	BIOHAVEN LTD	1,476,974	$80,776	10.8%	$49.52	0.0%	COM	G1110E107
—	ALPINE IMMUNE SCIENCES INC	1,982,016	$78,567	10.5%	$39.64	—	COM	02083G100
BEAM	BEAM THERAPEUTICS INC	2,119,598	$70,032	9.3%	$31.16	0.0%	COM	07373V105
APGE	APOGEE THERAPEUTICS INC	832,198	$55,300	7.4%	$43.66	0.0%	COM	03770N101
XNCR	XENCOR INC	1,109,650	$24,557	3.3%	$21.61	0.0%	COM	98401F105
SYRE	SPYRE THERAPEUTICS INC	473,200	$17,948	2.4%	$28.97	0.0%	COM NEW	00773J202
—	ELEVATION ONCOLOGY INC	2,332,928	$11,968	1.6%	$5.13	—	COM	28623U101
—	TOURMALINE BIO INC	465,000	$10,649	1.4%	$22.90	—	COM	89157D105
MRK	MERCK & CO INC	79,600	$10,503	1.4%	$115.77	0.0%	COM	58933Y105